{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:30:14Z","timestamp":1784338214853,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1925,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbmt.2009.11.014","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T05:07:20Z","timestamp":1259039240000},"page":"S82-S89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":237,"special_numbering":"S","title":["Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines"],"prefix":"10.1016","volume":"16","author":[{"given":"Alexandra","family":"Filipovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Grom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.11.014_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pbc.20112","article-title":"Outcome in children with pulmonary Langerhans cell Histiocytosis","volume":"43","author":"Braier","year":"2004","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib2","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.ejca.2005.02.007","article-title":"Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction","volume":"41","author":"Bernard","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM198910263211704","article-title":"The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis","volume":"321","author":"Dunger","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.11.014_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","article-title":"Risk factors for diabetes insipidus in Langerhans cell histiocytosis","volume":"46","author":"Grois","year":"2006","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2007.12.042","article-title":"Pattern and course of neurodegeneration in Langerhans cell histiocytosis","volume":"153","author":"Wnorowski","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2009.11.014_bib6","article-title":"Neurodegenerative central nervous system langerhans cell histiocytosis and coincident hydrocephalus: efficacy of vincrisitne cytosine arabinoside treatment","author":"Allen","year":"2009","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pbc.20181","article-title":"Langerhans cells in langerhans cell histiocytosis express CD 52 (Campath)","volume":"44","author":"Jordan","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1399-3046.2008.00989.x","article-title":"Hematopoietic stem cell transplantation in Langerhans cell histiocytosis: case report and review of the literature","volume":"13","author":"Kesik","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2009.11.014_bib9","article-title":"Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan","author":"Kudo","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.014_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1705015","article-title":"Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"36","author":"Steiner","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.014_bib11","first-page":"2976","article-title":"Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency","volume":"119","author":"Snow","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2009.11.014_bib12","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2009.11.014_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbmt.2009.11.014_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bbmt.2009.11.014_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bbmt.2009.11.014_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2009.11.014_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/pbc.21679","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"51","author":"Allen","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib19","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V73.8.2128.2128","article-title":"Elevated soluble interleukin-2 eceptor in childhood hemophagocytic histiocytic syndromes","volume":"73","author":"Komp","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.014_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","article-title":"Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis","volume":"129","author":"Horne","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.11.014_bib21","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3324\/haematol.13142","article-title":"Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP)","volume":"93","author":"Cesaro","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.11.014_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1705305","article-title":"Macrophage activation syndrome and other systemic inflammatory conditions after BMT","volume":"37","author":"Sreedharan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.014_bib23","article-title":"Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan","author":"Ohga","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2009.11.014_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","article-title":"Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis","volume":"107","author":"Cooper","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.014_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0022-3476(83)80704-5","article-title":"Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis","volume":"103","author":"Silverman","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2009.11.014_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bbmt.2009.11.014_bib27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive Haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"Stephan","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbmt.2009.11.014_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.20198","article-title":"NK dysfunction: a common pathway in systemic onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis","volume":"50","author":"Grom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2009.11.014_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J Peds"},{"key":"10.1016\/j.bbmt.2009.11.014_bib30","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bbmt.2009.11.014_bib31","article-title":"Mutations in the perforin gene can be linked to MAS in sJIA","author":"Vastert","year":"2009","journal-title":"PRES\/EULAR"},{"key":"10.1016\/j.bbmt.2009.11.014_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2009.11.014_bib33","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in systemic juvenile idiopathic arthritis is associated with MUNC13D gene polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2009.11.014_bib34","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.1780330814","article-title":"The soluble interleukin-2 receptor in rheumatic disease","volume":"33","author":"Rubin","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2009.11.014_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble IL2R\u03b1 chains in macrophage activation syndrome and untreated new onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2009.11.014_bib36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","article-title":"Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases","volume":"129","author":"Mouy","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2009.11.014_bib37","first-page":"241","article-title":"Macrophage activation syndrome after etanercept treatment","volume":"34","author":"Sandhu","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bbmt.2009.11.014_bib38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MPH.0b013e3180f61be3","article-title":"Use of Rituximab in conjunction with immunosuppressive chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis","volume":"29","author":"Balamuth","year":"2007","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"10.1016\/j.bbmt.2009.11.014_bib39","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in Children with severe progressive systmic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910900531X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910900531X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:36:40Z","timestamp":1761057400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910900531X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S108387910900531X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}